Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • U Offline
    U Offline
    ungeee
    wrote on sidst redigeret af
    #3

    21401 er kursen på GEN snart i følge seneste video TA-analyse fra TimerMarket

    1 Reply Last reply
    0
    • nohopeN Offline
      nohopeN Offline
      nohope
      wrote on sidst redigeret af
      #4

      Mon dog - mon dog -

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #5

        Aprilsnar eller for meget påskebryg 🙂

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #6

          BTK: Amerikansk biotech lægger an til positiv trendvending efter lang nedtur https://www.proinvestor.com/investornyt/673713/btk-amerikansk-biotech-laegger-an-til-positiv-trendvending-efter-lang-nedtur

          1 Reply Last reply
          0
          • K Offline
            K Offline
            Klarussen
            wrote on sidst redigeret af
            #7

            @ungeee: snarlig upside på 925%, lyder meget godt... men
            1000% var bedre.

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #8

              HexaBody®-CD38 also on clinicaltrials now https://www.clinicaltrials.gov/ct2/show/NCT04824794

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #9

                Just a moment...

                favicon

                (www.firstwordpharma.com)

                1 Reply Last reply
                0
                • U Offline
                  U Offline
                  ungeee
                  wrote on sidst redigeret af
                  #10

                  11.55, 12.31 11.26 - 210401 ville heller ikke være så tosset....og så undskyld til alle for mit uheldige forsøg 🙂 - god påske

                  1 Reply Last reply
                  0
                  • Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktørH Offline
                    Helge_LarsenPI-redaktør
                    wrote on sidst redigeret af
                    #11

                    God morgen. 🙂

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #12

                      GEN1046 Anticipated Enrollment ; large increase from 192 to 512
                      https://clinicaltrials.gov/ct2/history/NCT03917381?A=12&B=13&C=merged#StudyPageTop

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #13

                        this Amivantamab trial adds a chemo cohort https://clinicaltrials.gov/ct2/history/NCT04077463?A=17&B=18&C=merged#StudyPageTop

                        1 Reply Last reply
                        0
                        • JørgenVarnæsJ Offline
                          JørgenVarnæsJ Offline
                          JørgenVarnæs
                          wrote on sidst redigeret af
                          #14

                          Wow! Rather a large phase 1/2 study!!!

                          1 Reply Last reply
                          0
                          • JørgenVarnæsJ Offline
                            JørgenVarnæsJ Offline
                            JørgenVarnæs
                            wrote on sidst redigeret af
                            #15

                            That corresponds well with the optimal dose-statements made by biontech, you found a couple of days ago

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #16

                              yes, seems like a similar strategy as epcoritamab, also close to 500 in the Ph 1/2

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #17

                                small new Dara
                                trial for prospective kidney transplant recipients Daratumumab and Belatacept for Desensitization (ATTAIN) https://clinicaltrials.gov/ct2/show/NCT04827979

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #18

                                  I Gen1046 ændrer man protokol til også at indbefatte docetaxel. Det skulle vi spørge til ved næste Q&A.

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #19

                                    En godkendelse til isa https://www.fda.gov/drugs/drug-approvals-and-databases/fda-approves-isatuximab-irfc-multiple-myeloma?utm_medium=email&utm_source=govdelivery Ved ikke om det er en gammel nyhed på PI

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #20

                                      Considering the attractiv evaluation, upcoming news flow on key pipeline programs epcoritamab, tisotumab,and GEN1046, and seeing Genmab as one of those typical stocks to own when markets are jittery, we add Genmab to our best value list. https://www.proinvestor.com/index.php?p=debat_1&postid=92506

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #21

                                        Ja, meget kunne have set anderledes ud, hvis de ikke havde været så fedtede med guidance. Min ser således ud: us/row Q1 725/600 - Q2 775/650 - Q3 825/700 - Q4 875/775 - Y 3200/2725 - Total 5925. Endda forsigtig synes jeg. Hvordan ser jeres ud?

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #22

                                          Jeg synes også de er til den lave side. Tæt på $6bn er ikke skævt. Men vi må også erkende, at Genmab stort set har ramt skiven tidligere.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger